Searching for anti-glioma activity. Ribonucleoside analogues with modifications in nucleobase and sugar moieties.
Author(s) -
Grzegorz Framski,
Dariusz Wawrzyniak,
Zofia JahnzWechmann,
Agnieszka Szymańska-Michalak,
Adam Kraszewski,
Jan Barciszewski,
Jerzy Boryski,
Jacek Stawiński
Publication year - 2016
Publication title -
acta biochimica polonica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.452
H-Index - 78
eISSN - 1734-154X
pISSN - 0001-527X
DOI - 10.18388/abp.2016_1338
Subject(s) - ribonucleoside , nucleobase , guanine , hela , glioma , chemistry , cell culture , moiety , biochemistry , stereochemistry , cell , dna , cancer research , biology , rna , gene , nucleotide , genetics
Several ribonucleoside analogues with modifications in the nucleobase and sugar moiety have been screened for anti-glioma activity in the T98G glioma cell line using cervical (HeLa) cell line as reference human malignant cells, and lung fibroblast (MCR-5) cell line as non-cancerous reference cells. Among the investigated compounds, ribonucleosides containing 6-chloropurine (3), 7-guanine (5) and a pyrrolopyrimidine (18) as nucleobases, show promising anti-glioma activity with good selectivity indices, and can be considered as lead structures for further anti-cancer studies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom